Ectopic pregnancy refers to the pregnancy occurring outside the uterine cavity, predominantly i.e. 90% of them in the fallopian tube. Ectopic pregnancy affects 11 in 1000 pregnancies and is a significant cause of morbidity and at times mortality in the first trimester of pregnancy. In a 20-year longitudinal study on ectopic pregnancy in a defined
population of women aged 15e39 years the rate of ectopic pregnancy per 1000 diagnosed conceptions increased
from 5.8 during 1960e4 to 11.1 during 1975e9. The mean annual incidence of ectopic pregnancy per 1000 women
increased from 0.6 to 1.2 during the same period. The numbers of ectopic pregnancies per 1000 diagnosed
conceptions increased with increasing age of the women and were 4.1 in the teenage group, 6.9 in women aged
20e29 years, and 12.9 in women aged 30e39.
3. Medical management of ectopic pregnancy
Fig. 1 Risk of ectopic pregnancy according to maternal age at
conception.
d
d
d
d
d
d
d
d
d
Use of an intrauterine device (IUD), a form of birth
control, at the time of conception.
History of pelvic inflammatory disease (PID).
Sexually-transmitted diseases such as chlamydia and
gonorrhea.
Congenital abnormality (problem present at birth) of the
fallopian tube.
History of pelvic surgery (since scarring may block the
fertilized egg from leaving the fallopian tube).
History of ectopic pregnancy.
Unsuccessful tubal ligation (surgical sterilization) or
tubal ligation reversal.
Fertility drugs.
Infertility treatments such as in vitro fertilization (IVF).
SYMPTOMS
Common symptoms include:
d
Light vaginal bleeding
d
Nausea and vomiting
d
Lower abdominal pain
d
Sharp abdominal cramps
d
Pain on one side of the body
d
Dizziness or weakness
d
Pain in the shoulder, neck, or rectum
If the fallopian tube ruptures, the pain and bleeding
could be severe enough to cause fainting.5
Review Article
199
rupture allows for outpatient treatment, reducing the risk of
major complications and future infertility. Delay in diagnosis
might lead to rupture, resulting in intra-abdominal hemorrhage, need for laparotomy, blood transfusion, and death.
Abdominal pain or vaginal bleeding in the first trimester is
the only clinical signs and symptoms of ectopic pregnancy,
but they are not sensitive or specific. Most women with
such symptoms have normal intrauterine pregnancies; therefore, diagnosis of ectopic pregnancy must be accurate and
timely, but should use methods that do not interrupt viable
intrauterine pregnancies. Several published protocols for
diagnosing women at risk for ectopic pregnancy use clinical
examination, transvaginal ultrasonography, serum quantitative hCG, and serum progesterone selectively and in various
permutations, but no approach has been established to be
superior to others.
Identification of ectopic pregnancy can be difficult by
ultrasound, so the most efficient way to rule out ectopic pregnancy is to diagnose intrauterine pregnancy. The sensitivity
of ultrasound for diagnosing intrauterine pregnancy
approaches 100% in gestations greater than 5.5 weeks. Often,
exact gestational age is not known at evaluation and serum
hCG is used as a surrogate marker for it. The discriminatory
zone is defined as the serum hCG level above which ultrasound is expected to detect a viable intrauterine pregnancy.
Often used in the evaluation of early pregnancy, the hCG
discriminatory zone is based on the assumption that a serum
b-hCG level exceeding 1000e2000 mIU/mL in a woman
who has a normal intrauterine pregnancy should be accompanied by a gestational sac that is visible via transvaginal Ultra
Sonography.6 When an intrauterine pregnancy is not visualized on ultrasound with hCG above the discriminatory zone,
we presume the gestation is nonviable or ectopic. In those
circumstances, a D&C is done to confirm intrauterine pregnancy. Without endometrial curettings with chorionic villi,
ectopic pregnancy is presumed. Transvaginal ultrasound
and quantitative hCGs are routinely used in diagnostic strategies, but there is debate about which should be done first.
There has been much literature suggesting serum progesterone might aid diagnosis of ectopic pregnancy. A single
serum progesterone level above 25 ng/mL is strongly associated with a normal intrauterine pregnancy, whereas levels
below 5 ng/mL are associated with abnormal gestations
(ectopic or abnormal intrauterine pregnancy).7
TREATMENT
DIAGNOSIS
Surgical treatment
Despite increasing incidence, the mortality rate associated
with ectopic pregnancy has fallen dramatically, Thanks to
improved diagnostic methods. Early detection before tubal
If you have an ectopic pregnancy that is causing severe symptoms, bleeding, or high hCG levels, surgery is usually
4. 200
Apollo Medicine 2012 September; Vol. 9, No. 3
needed. This is because medicine is not likely to work and
a rupture becomes more likely as time passes. When possible,
laparoscopic surgery that uses a small incision is done. For
a ruptured ectopic pregnancy, emergency surgery is needed.8
The current gynecology supports the use of a laparoscopic
approach prospective (Fig. 2) and randomized clinical trials
demonstrate that the laparoscopic approach when compared
with laparotomy is associated with less estimated blood
loss, shorter postoperative hospitalization and reduced cost.
The two approaches are similar with respect to tubal patency
rates and intrauterine pregnancy rates.3
Medical treatment
Until the mid 1980s treatment for ectopic pregnancy was
exclusively surgical. During that decade medical management with drugs like methotrexate was first introduced to
avoid the need for surgical intervention. The decision about
whether to use medical therapy for ectopic, which patients
should be treated, which protocol to be used and when to
convert to surgery during medical treatment can be difficult
choices. In determining whether a patient is a candidate for
medical therapy, a number of factors must be considered.
She must be hemodynamically stable, with no signs or
symptoms of active bleeding or hemoperitoneum. Furthermore, she must be reliable, compliant, and able to return
for follow-up. Another factor is size of the gestation, which
should not exceed 3.5 cm at its greatest dimension on US
measurement. She should not have any contraindications
to the use of methotrexate.9
Initial protocols required prolonged hospitalization and
multiple doses of methotrexate. They were associated
with significant side effects. Refinement in protocols have
allowed outpatient therapy that often require only single
dose of methotrexate and are associated with fewer side
Shetty et al.
effects. Protocols using other agents like potassium chloride, Dactinomycin, prostaglandins and RU 486 for medical
management have also been developed. These agents may
be administered by direct injection into the ectopic sac or
in the cases of Dactinomycin, prostaglandins and RU 486
given systemically by oral, intramuscular or intravenous
routes. However due to limited experience with these
agents their use must be considered experimental till additional data are available.
Evidence shows little difference in the psychological
outcomes when comparing surgical and medical methods
of management of ectopic pregnancy treatment with single
dose methotrexate in ectopic pregnancy is associated with
sparing on treatment costs.10
Monitoring and follow-up of patients
Following treatment (medical or surgical) patients are
examined weekly and serial hCG levels should be taken
until the levels are undetectable. If the levels do not decline,
the patient can be treated with a second course of methotrexate or with a post-surgical course of methotrexate; in
this case subsequent monitoring is with weekly serial
hCG and transvaginal ultrasound until hCG is <10 U/L
(<10 mU/mL). Increasing levels thereafter are treated
surgically. Once the serum hCG levels are undetectable,
no further monitoring is needed.
While some experts recommend follow-up hCG only after
medical management or salpingostomy, persistent trophoblastic tissue has been reported after salpingectomy as well.
Therefore, it is good practice to follow-up hCG even after salpingectomy, although it might not be as crucial as after salpingostomy or medical management. Patients with
a history of a previous ectopic pregnancy should be encouraged to present and be evaluated early with subsequent pregnancies to rule out the recurrence of an ectopic pregnancy.
Surgery v/s medicine
d
d
d
Fig. 2 Ectopic pregnancy laparoscopic picture of an unruptured right ampullary tubal pregnancy with bleeding out of the
fimbriated end resulting in hemoperitoneum.1
Methotrexate is usually the first treatment choice for
ending an early ectopic pregnancy. Regular follow-up
blood tests are needed for days to weeks after the medicine is injected.
There are different types of surgery for a tubal ectopic
pregnancy-when possible, only a slit is made in the fallopian tube (salpingostomy), rather than removing
a section of the tube (salpingectomy).
On average, salpingostomy is equal to methotrexate (for an
early ectopic pregnancy) in terms of being effective and
preserving a woman’s ability to become pregnant in the
future.
5. Medical management of ectopic pregnancy
d
Although surgery is a faster treatment, it can cause scar
tissue that could cause future pregnancy problems. Tubal
surgery may damage the fallopian tube, depending on
where and how big the embryo is and the type of surgery
needed.8
CONCLUSION
Data shows that change in life style, late marriages,
increases in maternal age at conception are the main causes
of Ectopic pregnancies. Diagnosis of ectopic pregnancy
must be accurate and timely, but should use methods that
do not interrupt viable intrauterine pregnancies, diagnosing
women at risk for ectopic pregnancy use clinical examination, transvaginal ultrasonography, serum quantitative hCG,
and serum progesterone selectively.7
Ectopic Pregnancy can be treated both surgically and
medically. Women should be carefully advised when ever
possible of the advantages and disadvantages associated
with each approach used for treatment of ectopic pregnancy
and participate fully in selection of the appropriate treatment.
CONFLICTS OF INTEREST
All authors have none to declare.
REFERENCES
1. Vicken P Sepilian, MD, MSc, Medical Director. Reproductive
Endocrinology and Infertility, CHA Fertility Center. Ectopic
pregnancy.
http://emedicine.medscape.com/article/258768overview.
Review Article
201
2. Stephen Metz, MD. Ectopic pregnancy. http://www.
emedicinehealth.com/ectopic_pregnancy/article_em.htm.
3. Stovall Thomas G. Medical Management of Ectopic Pregnancy,
http://journals.lww.com/co-obgyn/Abstract/1994/12000/
Medical_management_of_ectopic_pregnancy.7.aspx; 1994.
4. Maternal age and fetal loss: population based register linkage
study. BMJ, http://www.bmj.com/content/320/7251/1708?
ijkey¼2dc682363be59c50da8c3d644e26de349ec20aa7&key
type2¼tf_ipsecsha&linkType¼ABST&journalCode¼bmj&
resid¼320/7251/1708; 2000.
5. Web MD. Health and Ectopic Pregnancy, http://www.webmd.
com/baby/pregnancy-ectopic-pregnancy; 2012.
6. Is the hCG discriminatory zone a reliable indicator of intrauterine or Ectopic Pregnancy Doubilet PM, Benson CB.
Further evidence against the reliability of the human chorionic
gonadotropin discriminatory level. J Ultrasound Med.
2011;30(12):1637e1642. http://www.obgmanagement.com/
article_pages.asp?aid¼10193&uid¼.
7. Gracia Clarisa R MD, Barnhart Kurt T MD, MSCE. Diagnosing Ectopic Pregnancy: Decision Analysis Comparing
Six Strategies, http://journals.lww.com/greenjournal/Abstract/
2001/03000/Diagnosing_Ectopic_Pregnancy__Decision_
Analysis.28.aspx; 2001.
8. Health and Pregnancy. Ectopic Pregnancy e Treatment Overview,
http://www.webmd.com/baby/tc/ectopic-pregnancy-treatmentoverview; June 21, 2012.
9. Medscape Sepilian Vicken P. Ectopic Pregnancy Treatment &
Management, http://emedicine.medscape.com/article/258768treatment; Mar 26, 2012.
10. American Society for Reproductive Health. Medical Treatment
of Ectopic Pregnancy, http://www.asrm.org/uploadedFiles/
ASRM_Content/News_and_Publications/Practice_Guide
lines/Technical_Bulletins/Medical_treatment(1).pdf; 2008.
6. A o oh s i l ht:w wa o o o p a . m/
p l o p a : t / w .p l h s i lc
l
ts p /
l
ts o
T ie: t s / ie. m/o p a A o o
wt rht :t t r o H s i l p l
t
p /w t c
ts
l
Y uu e ht:w wy uu ec m/p l h s i ln i
o tb : t / w . tb . a o o o p a i a
p/
o
o
l
ts d
F c b o : t :w wfc b o . m/h A o o o p a
a e o k ht / w . e o k o T e p l H s i l
p/
a
c
l
ts
Si s ae ht:w wsd s aen t p l _ o p a
l e h r: t / w .i h r.e/ o o H s i l
d
p/
le
A l
ts
L k d : t :w wl k d . m/ mp n /p l -o p a
i e i ht / w . e i c c a y o oh s i l
n n p/
i
n no o
a l
ts
Bo : t :w wl s l e l . /
l ht / w . t a h a hi
g p/
e tk t n